8 employees
Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.
2015
$5M
from 2 investors over 2 rounds
Kedalion Therapeutics raised undisclosed on November 15, 2021
Investors: Lagunita Biosciences
Kedalion Therapeutics raised $5M on August 6, 2018